地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：18995651644
传真：18771149750
邮箱：sales@amyjet.com
艾美捷科技特约代理BioPAL全系列产品。
BioPAL公司位于美国马萨诸塞Worcester，服务于生命科学和生物医药行业，主要从事非放射性报告系统的研发、生产、商业化。此外，BioPAL销售用于核磁共振（MRI）的纳米颗粒；BioPAL还提供即用型的细胞标记及示踪产品。
BioPhysics Assay Laboratory (BioPAL, Inc.) is a privately held, for-profit company based in Worcester Massachusetts. The company develops and sells novel tools for the life science and biomedical communities. BioPAL was the first company to commercialize non-radioactive products that use neutron activation technology as the read-out system. The company also develops and sells nanoparticles for applications in magnetic resonance imaging (MRI), magnetic separation applications and tools for time resolved fluorescent technology. BioPAL offers ready-to-use cell labeling and tracking products for cellular therapy research applications.
BioPAL was the first to introduce functional immunoassay technology (FIT) to the research community. The company offers a line of renal diagnostics based on FIT to measure glomerular filtration rate (GFR) and effective renal blood flow (RBF). Most notably is BioPAL's ELISA kit for the measurement of inulin.
BioPAL公司的主要产品包括：
Pre-Clinical Imaging Agents
Kidney Diagnostics
Microspheres for Blood Flow Studies
Dead-Cell Removal Kits - Viahanc
Products for Cellular Therapy Research
" data-original="http://gropep.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技特约代理BioPAL全系列产品"> 艾美捷科技特约代理BioPAL全系列产品
艾美捷科技代理Imagion Biosystems公司产品。
Imagion Biosystems公司提供高品质的PrecisionMRX®系列氧化铁(Fe3O4)纳米颗粒。PrecisionMRX®纳米颗粒是具有均匀球形形态、
窄尺寸的超顺磁性氧化铁纳米颗粒，特点是分散性和高磁弛豫性。为了达到最高质量，Imagion Biosystems使用热分解工艺，该工艺可
以精确控制纳米颗粒的尺寸、形状和磁性，并保持最小的批间差异。
Carboxylic Acid Functionalized PrecisionMRX® Nanoparticles
Size：10mg/50mg
Dextran-Coated PrecisionMRX® Nanoparticles
Size：10mg/5mg
mPEG Coated PrecisionMRX® Nanoparticles
Size：10mg/5mg
Oleic Acid Coated PrecisionMRX® Nanoparticles
Size：100mg/50mg
Accurate Chemical & Scientific Corporation公司成立于1974年，标准化流程生产高质量多克隆和单克隆抗体。公司市场覆盖广泛客户群体和应用领域，未政府实验室、大学研究中心、制药实验室以及医院临床中心服务。
1974 saw the incorporation of Accurate Chemical & Scientific Corporation. Accurate pioneered and introduced standardized, highly characterized polyclonal and monoclonal antibodies. Since 1975, Accurate has specialized in products for basic and R&D research as well as routine laboratory work. Accurate's market covers a broad range of customers and applications, serving government labs, university research centers, pharmaceutical laboratories, as well as hospitals, clinical and industrial centers.
Accurate chemical公司的主要产品包括：
Antibodies and Antigens
Monoclonal antibodies
Polyclonal antibodies
Lab Equipment
Biocolor Assay Kits
Cell Separation Media
" data-original="http://gropep.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Accurate Chemical"> Accurate Chemical
Anogen-Yes Biotech Laboratories Ltd. 创建于1989年, 位于加拿大多伦多近郊的著名高科技城市密西沙加市。Anogen是加拿大逸士生物技术研究有限公司在国际上的市场经销部门。Anogen-Yes Biotech Laboratories Ltd.研发和生产各种新颖抗体及有关产品，应用广泛的技术平台设计和开发各种单克隆抗体、多克隆抗体、基因工程/人源化抗体、免疫检验用配对抗体、免疫球蛋白、活性多肽、酶联免疫试剂盒[ELISA]、斑点酶联免疫试剂盒[Elispots]和基因重组蛋白质等等。 这些产品主要用于生命科学研究和各种疾病的诊断和防治,包括炎症和自身免疫性疾病、心血管病和癌症等。
Anogen is the trade name of Yes Biotech Laboratories Ltd., a Canadian biopharmaceutical company based in Mississauga, Ontario. Founded in 1989, Anogen-Yes Biotech specializes in developing and manufacturing monoclonal antibodies, recombinant proteins, synthetic bioactive peptides, and Enzyme linked immunosorbent assay (ELISA) kits for research as well as diagnostic and therapeutic use.[1] It is also committed to seeking medical treatment of cancer, autoimmune, inflammatory and cardiovascular diseases by developing antibody-based biopharmaceuticals.
Anogen的主要产品包括：
Monoclonal Antibodies
Polyclonal Antibodies
Matched Antibody Pairs
ELISA Kits
按照研究领域细分：
Inflammatory & Growth Factors
Cell Biology & Molecular Biology
Immunoassay Reagents
Infection & Toxin
Coagulation Factors
Hormone
Neurological Disorder
Tumor Research
| 品名 | 货号 | 规格 |
| mAb anti-Human TNF-α, CH8810 | MO-C40003A | 0.1 mg |
| mAb anti-Human TNF-α, CH8820, Capture | MO-C40003B | 0.1 mg |
| mAb anti-Human TNF-α, C2H9 | MO-C40003D | 0.1 mg |
| mAb anti-Human TNF-α, B1E4, Detector | MO-C40003E | 0.1 mg |
| mAb anti-Human TNF-α, C2A7 | MO-C40003F | 0.1 mg |
| mAb anti-Human TNF-α, C5G7 | MO-C40003G | 0.1 mg |
| mAb anti-Human TNF-α, C4C7 | MO-C40003H | 0.1 mg |
| mAb anti-Human IFN-γ, 315 | MO-C40004D | 0.1 mg |
| mAb anti-Human IFN-γ, 165 | MO-C40004E | 0.1 mg |
| mAb anti-Human IFN-γ, 23 | MO-C40004F | 0.1 mg |
| mAb anti-Human CCR1, 293 | MO-C40005A | 0.1 mg |
| mAb anti-Human TGF-β, TB21 | MO-C40009A | 0.1 mg |
| mAb anti-Human TGF-β, 2C5 | MO-C40009B | 0.1 mg |
| mAb anti-Human TGF-β, 2C6 | MO-C40009D | 0.1 mg |
| mAb anti-Human TGF-β, 2E6 | MO-C40009E | 0.1 mg |
| mAb anti-Human TGF-β, 8C4 | MO-C40009F | 0.1 mg |
| mAb anti-Human IL-8, I8-S2, Capture | MO-C40017A | 0.1 mg |
| mAb anti-Human IL-8, I8-60, Detector | MO-C40017D | 0.1 mg |
| mAb anti-Human IL-8, I8-61 | MO-C40017E | 0.1 mg |
| mAb anti-Human IL-8, 257 | MO-C40017F | 0.1 mg |
| mAb anti-Human IL-8, 807 | MO-C40017G | 0.1 mg |
| mAb anti-Human MCP-1, S8 | MO-C40021A | 0.1 mg |
| mAb anti-Human MCP-1, S14, Capture | MO-C40021B | 0.1 mg |
| mAb anti-Human MCP-1, S101, Detector | MO-C40021D | 0.1 mg |
| mAb anti-Human MCP-1, 9G10 | MO-C40021E | 0.1 mg |
| mAb anti-Human MCP-1, S382 | MO-C40021F | 0.1 mg |
| mAb anti-Human SAA, 115, Capture | MO-C40028A | 0.1 mg |
| mAb anti-Human SAA, 513 | MO-C40028D | 0.1 mg |
| mAb anti-Human SAA, 607, Detector | MO-C40028E | 0.1 mg |
| mAb anti-Human SAA, 291 | MO-C40028G | 0.1 mg |
| mAb anti-Human SAA, 504 | MO-C40028H | 0.1 mg |
| mAb anti-Human SAA, 585 | MO-C40028J | 0.1 mg |
| mAb anti-Human SAA, 426 | MO-C40028K | 0.1 mg |
| mAb anti-Human SAA, 38 | MO-C40028L | 0.1 mg |
| mAb anti-Human SAA, 132 | MO-C40028M | 0.1 mg |
| mAb anti-Human SAA, S3 | MO-C40028N | 0.1 mg |
| mAb anti-Human IL-1β, S1H12 | MO-C40029A | 0.1 mg |
| mAb anti-Human IL-1β, S1B7 | MO-C40029B | 0.1 mg |
| mAb anti-Human IL-1β, S3F12 | MO-C40029G | 0.1 mg |
| mAb anti-Human IL-1β, 464 | MO-C40029H | 0.1 mg |
| mAb anti-Human IL-2, 5A8, | MO-C40032A | 0.1 mg |
| mAb anti-Human IL-2, 9F9, | MO-C40032B | 0.1 mg |
| mAb anti-Human IL-2, 10C4 | MO-C40032C | 0.1 mg |
| mAb anti-Human IL-2, 8C2 | MO-C40032D | 0.1 mg |
| mAb anti-Human IL-2, 6F11 | MO-C40032E | 0.1 mg |
| mAb anti-Human IL-2, 6B1 | MO-C40032F | 0.1 mg |
| mAb anti-Human EGF, S-21 | MO-C40044A | 0.1 mg |
| mAb anti-Human EGF, S-120 | MO-C40044B | 0.1 mg |
| mAb anti-Human EGF, S-134, Capture | MO-C40044D | 0.1 mg |
| mAb anti-Human EGF, S-145 | MO-C40044E | 0.1 mg |
| mAb anti-Human EGF, S-146, Detector | MO-C40044F | 0.1 mg |
| mAb anti-Human EGF, S-147 | MO-C40044G | 0.1 mg |
| mAb anti-Human EGF, S-177 | MO-C40044H | 0.1 mg |
| mAb anti-Human G-CSFR, S-1252 | MO-C40045A | 0.1 mg |
| mAb anti-Human G-CSFR, S-1268 | MO-C40045B | 0.1 mg |
| mAb anti-Human G-CSFR, S-1284 | MO-C40045D | 0.1 mg |
| mAb anti-Human G-CSFR, S-1374 | MO-C40045E | 0.1 mg |
| mAb anti-Human G-CSFR, S-425 | MO-C40045F | 0.1 mg |
| mAb anti-Human G-CSFR, S-1390 | MO-C40045G | 0.1 mg |
| mAb anti-Human bFGF, F-343 | MO-C40046A | 0.1 mg |
| mAb anti-Human bFGF, F-74 | MO-C40046B | 0.1 mg |
| mAb anti-Human bFGF, F-474 | MO-C40046F | 0.1 mg |
| mAb anti-Human bFGF, F-3 | MO-C40046H | 0.1 mg |
| mAb anti-Human EPO, 85 | MO-C40047A | 0.1 mg |
| mAb anti-Human M-CSF, 116 | MO-C40048A | 0.1 mg |
| mAb anti-Human M-CSF, 692 | MO-C40048B | 0.1 mg |
| mAb anti-Human M-CSF, 21 | MO-C40048D | 0.1 mg |
| mAb anti-Human MIP-1α, 116 | MO-C40051A | 0.1 mg |
| mAb anti-Human MIP-1α, 125 | MO-C40051D | 0.1 mg |
| mAb anti-Human MIP-1α, 548 | MO-C40051F | 0.1 mg |
| mAb anti-Human MIP-1α, 199 | MO-C40051G | 0.1 mg |
| mAb anti-Human MIP-1α, 400 | MO-C40051L | 0.1 mg |
| mAb anti-Human MIP-1α, 103 | MO-C40051M | 0.1 mg |
| mAb anti-Human MIP-1α, 376 | MO-C40051N | 0.1 mg |
| mAb anti-Human MIP-1α, 426 | MO-C40051P | 0.1 mg |
| mAb anti-Human MCP-3, 113, Detector | MO-C40088A | 0.1 mg |
| mAb anti-Human MCP-3, 343 | MO-C40088B | 0.1 mg |
| mAb anti-Human MCP-3, 490 | MO-C40088D | 0.1 mg |
| mAb anti-Human MCP-3, 768 | MO-C40088E | 0.1 mg |
| mAb anti-Human MCP-3, 1057 | MO-C40088F | 0.1 mg |
| mAb anti-Human MCP-3, 542, Capture | MO-C40088G | 0.1 mg |
| mAb anti-Human MCP-3, 1015 | MO-C40088H | 0.1 mg |
| mAb anti-Human IL-16, 59 | MO-C40089G | 0.1 mg |
| mAb anti-Human IL-16, 210 | MO-C40089H | 0.1 mg |
| mAb anti-Human IL-16, 323, Detector | MO-C40089J | 0.1 mg |
| mAb anti-Human IL-16, 398, Capture | MO-C40089K | 0.1 mg |
| mAb anti-Human IL-16, 568 | MO-C40089M | 0.1 mg |
| mAb anti-Human IL-16, 572 | MO-C40089N | 0.1 mg |
| mAb anti-Human GM-CSF, 29 | MO-C40090A | 0.1 mg |
| mAb anti-Human GM-CSF, 59, Capture | MO-C40090B | 0.1 mg |
| mAb anti-Human GM-CSF, 429, Detector | MO-C40090D | 0.1 mg |
| mAb anti-Human GM-CSF, 204 | MO-C40090E | 0.1 mg |
| mAb anti-Human GM-CSF, 489 | MO-C40090F | 0.1 mg |
| mAb anti-Human GM-CSF, 120 | MO-C40090G | 0.1 mg |
| mAb anti-Human GM-CSF, 26 | MO-C40090H | 0.1 mg |
| mAb anti-Human GM-CSF, 174 | MO-C40090K | 0.1 mg |
| mAb anti-Human GM-CSF, S333 | MO-C40090L | 0.1 mg |
| mAb anti-Human IL-6, 2E10 | MO-C40091B | 0.1 mg |
| mAb anti-Human IL-6, 8E10 | MO-C40091C | 0.1 mg |
| mAb anti-Human IL-6, 5G8 | MO-C40091D | 0.1 mg |
| mAb anti-Human IL-6, 1B6 | MO-C40091E | 0.1 mg |
| mAb anti-Human IL-6, 1E3 | MO-C40091F | 0.1 mg |
| mAb anti-Human IL-6, 6D7 | MO-C40091G | 0.1 mg |
| mAb anti-Human IL-6, 9D8 | MO-C40091H | 0.1 mg |
| mAb anti-Human IL-10, 4H2 | MO-C40092A | 0.1 mg |
| mAb anti-Human IL-10, 6D2 | MO-C40092B | 0.1 mg |
| mAb anti Human IL-17A clone 4C1, Capture | MO-C40093A | 0.1mg |
| mAb anti Human IL-17A clone 2F3 | MO-C40093B | 0.1mg |
| mAb anti Human IL-17A clone 8H7 | MO-C40093C | 0.1mg |
| mAb anti Human IL-17A clone 5B4 | MO-C40093D | 0.1mg |
| mAb anti Human IL-17A clone 1E2 | MO-C40093E | 0.1mg |
| mAb anti Human IL-17A clone 2D11 | MO-C40093H | 0.1mg |
| mAb anti Human IL-17A clone 3C1 | MO-C40093I | 0.1mg |
| mAb anti Human IL-17A clone 3H11, Detector | MO-C40093K | 0.1mg |
| mAb anti Human IL-17A clone 5A9 | MO-C40093M | 0.1mg |
| mAb anti Human IL-17A clone 6F12 | MO-C40093O | 0.1mg |
| mAb anti Human IL-17A clone 7F10 | MO-C40093S | 0.1mg |
| mAb anti Human IL-17A clone 10F9 | MO-C40093W | 0.1mg |
| mAb anti Human IL-18 clone 2A10, Capture | MO-C40094A | 0.1mg |
| mAb anti Human IL-18 clone 10H4, Detector | MO-C40094B | 0.1mg |
| mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled) | MO-C40094TB | 0.1 mL |
| mAb anti Human IL-15 clone 5E8, Capture | MO-C40095A | 0.1mg |
| mAb anti Human IL-15 clone B1H6, Detector | MO-C40095B | 0.1mg |
| mAb anti-human LIF, Clone 2C6 | MO-C40096A | 0.1mg |
| mAb anti-human LIF, Clone 3F4 | MO-C40096B | 0.1mg |
| mAb anti-human LIF, Clone 8B10 | MO-C40096C | 0.1mg |
| mAb anti-DYKDDDDK (Flag) Tag, Flag.10F4 | MO-H40001B | 0.1 mg |
| mAb anti-GAPDH, H8 | MO-H40002A | 0.1 mg |
| mAb anti-HA Tag, HA52 | MO-H40004A | 0.1 mg |
| mAb anti-His Tag, 10A12 | MO-H40005B | 0.1 mg |
| mAb anti-Myc Tag, MycA7 | MO-H40006A | 0.1 mg |
| mAb anti-V5 Tag, V531 | MO-H40007A | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 473, Detector | MO-I40002A | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 163 | MO-I40002C | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 340, Capture | MO-I40002D2 | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 587, 0.1 mg | MO-I40002E | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 425 | MO-I40002I | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 1027 | MO-I40002J | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 287 | MO-I40002N | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 161 | MO-I40002P | 0.1 mg |
| mAb anti-HBsAg, RM-1 | MO-I40013A | 0.1 mg |
| mAb anti-HCV Core Protein, A1/3D1 | MO-I40015A | 0.1 mg |
| mAb anti-HCV Core Protein, B2 | MO-I40015B | 0.1 mg |
| mAb anti-HCV Core Protein, C3 | MO-I40015E | 0.1 mg |
| mAb anti-HCV NS-4, 7B7/5G9 | MO-I40016B | 0.1 mg |
| mAb anti-HCV NS-4, 5D4/10E7 | MO-I40016D | 0.1 mg |
| mAb anti-HCV NS-4, 7E11 | MO-I40016F | 0.1 mg |
| mAb anti-HCV NS-4, 202 | MO-I40016J | 0.1 mg |
| mAb anti-HCV NS-4, 101 | MO-I40016K | 0.1 mg |
| mAb anti-HCV NS-4, 174 | MO-I40016L | 0.1 mg |
| mAb anti-HCV NS-4, 497 | MO-I40016M | 0.1 mg |
| mAb anti-HCV NS-3, 70-13 | MO-I40018A | 0.1 mg |
| mAb anti-HCV NS-3, 1-5 | MO-I40018B | 0.1 mg |
| mAb anti-HCV NS-3, 12-15 | MO-I40018D | 0.1 mg |
| mAb anti-HCV NS-3, 5-11 | MO-I40018E | 0.1 mg |
| mAb anti-HCV NS-3, 24-8 | MO-I40018F | 0.1 mg |
| mAb anti-HCV NS-3, 20-8 | MO-I40018G | 0.1 mg |
| mAb anti-HCV NS-3, 113 | MO-I40018H | 0.1 mg |
| mAb anti-HCV NS-3, 281 | MO-I40018J | 0.1 mg |
| mAb anti-HCV NS-3, 806 | MO-I40018K | 0.1 mg |
| mAb anti-HCV NS-3, 5 | MO-I40018L | 0.1 mg |
| mAb anti-HCV NS-3, 328 | MO-I40018M | 0.1 mg |
| mAb anti-HCV NS-3, 251 | MO-I40018N | 0.1 mg |
| mAb anti-HCV NS-3, 242 | MO-I40018P | 0.1 mg |
| mAb anti-HCV NS-3, 133 | MO-I40018Q | 0.1 mg |
| mAb anti-HEV, S-13 | MO-I40019B | 0.1 mg |
| mAb anti-HEV, 4H5 | MO-I40019C | 0.1 mg |
| mAb anti-HEV, 2H6 | MO-I40019D | 0.1 mg |
| mAb anti-HEV, 2H2 | MO-I40019E | 0.1 mg |
| mAb anti-HEV, 1B6 | MO-I40019F | 0.1 mg |
| mAb anti-HEV, 5H4 | MO-I40019G | 0.1 mg |
| mAb anti-HP CagA, 10E9, | MO-I40020A | 0.1 mg |
| mAb anti-HP CagA, 5H10 | MO-I40020B | 0.1 mg |
| mAb anti-HP CagA, 5C6 | MO-I40020C | 0.1 mg |
| mAb anti-HP CagA, 3C10, | MO-I40020D | 0.1 mg |
| mAb anti-HP CagA, 3C1 | MO-I40020E | 0.1 mg |
| mAb anti-TB 38KD Antigen, D2G2 | MO-I40021A | 0.1 mg |
| mAb anti-TB 38KD Antigen, C12H11 | MO-I40021B | 0.1 mg |
| mAb anti-TB 38KD Antigen, C11B10 | MO-I40021C | 0.1 mg |
| mAb anti-TB 38KD Antigen, B12F8 | MO-I40021D | 0.1 mg |
| mAb anti-TB 38KD Antigen, A11D2 | MO-I40021E | 0.1 mg |
| mAb anti-TB 38KD Antigen, A2H8 | MO-I40021F | 0.1 mg |
| mAb anti-Human CD3, JXT3 | MO-L40001A | 0.1 mg |
| Rat anti-Mouse CD4, JXYT4 | MO-L40026 | 0.1 mg |
| Rat anti-Mouse CD8, JXYT8 | MO-L40027 | 0.1 mg |
| mAb anti-Human CD11α, A11 | MO-L40028 | 0.1 mg |
| mAb anti-Human HLA-ABC, LY5.1 | MO-L40033 | 0.1 mg |
| mAb anti-Human CD71 Transferrin Receptor, CY-TFR | MO-L40042 | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 1C4 | MO-L40043A | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 7C9, Capture | MO-L40043B | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 9E11 | MO-L40043E | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 9B4 | MO-L40043F | 0.1 mg |
| mAb anti-Human PD-1 / CD279, B1C4 | MO-L40043G | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 7G12, Detector | MO-L40043L | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 2H7 | MO-L40043M | 0.1 mg |
| mAb anti Human PD-L1, clone 6A5 | MO-L40044E | 0.1 mg |
| mAb anti Human PD-L1 clone 8C12 | MO-L40044F | 0.1 mg |
| mAb anti Human PD-L1 clone 12B4, Detector | MO-L40044I | 0.1 mg |
| mAb anti Human PD-L1 clone 11D11 | MO-L40044M | 0.1 mg |
| mAb anti Human PD-L1 clone 15G3, Capture | MO-L40044N | 0.1 mg |
| mAb anti Human PD-L1 clone 12D9 | MO-L40044O | 0.1 mg |
| mAb anti Human PD-L1 clone 15F2 | MO-L40044R | 0.1 mg |
| mAb anti Human PD-L1, clone 10B12 | MO-L40044S | 0.1 mg |
| mAb anti Human CD47, clone 1G10 | MO-L40045A | 0.1 mg |
| mAb anti Human CD47, clone 8H7 | MO-L40045B | 0.1 mg |
| mAb anti Human CD47, clone 9F10 | MO-L40045C | 0.1 mg |
| mAb anti Human CD44, clone 2G7 | MO-L40046A | 0.1 mg |
| mAb anti Human CD44, clone 3C7 | MO-L40046B | 0.1 mg |
| mAb anti-hCG-α, CH5 | MO-M40010A | 0.1 mg |
| mAb anti-hCG-α, CH7 | MO-M40010B | 0.1 mg |
| mAb anti-TRICHOSANTHIN (TCST), TCST-1, 0.1 mg | MO-M40011A | 0.1 mg |
| mAb anti-hGH, YC6, Capture | MO-M40012A | 0.1 mg |
| mAb anti-Human Ig Kappa Light Chain, YCK1 | MO-M40020 | 0.1 mg |
| mAb anti-Human B2MG, D6E4 | MO-M40021B | 0.1 mg |
| mAb anti-Human B2MG, D2E9, Capture | MO-M40021C | 0.1 mg |
| mAb anti-Human B2MG, D6D1 | MO-M40021D | 0.1 mg |
| mAb anti-Human B2MG, D2A10 | MO-M40021E | 0.1 mg |
| mAb anti-Human B2MG, D3A2, Detector | MO-M40021F | 0.1 mg |
| mAb anti-human CRP, 63F4, Capture | MO-M40023A | 0.1 mg |
| mAb anti-human CRP, 67A1 | MO-M40023B | 0.1 mg |
| mAb anti-human CRP, N1G1 | MO-M40023D | 0.1 mg |
| mAb anti-human CRP, S5G1 | MO-M40023E | 0.1 mg |
| mAb Rat anti-Aflatoxin, 1C6, 0.1 mg | MO-M40025A | 0.1 mg |
| mAb Rat anti-Aflatoxin, 1E6, 0.1 mg | MO-M40025B | 0.1 mg |
| mAb Rat anti-Aflatoxin, 2E4 | MO-M40025D | 0.1 mg |
| mAb anti-Human Albumin, S4D6 | MO-M40036 | 0.1 mg |
| mAb anti-Human Factor IX, F9-1, .01 mg | MO-M40037 | 0.1 mg |
| mAb anti-Human Protein C, HLW-C, 0.1 mg | MO-M40038 | 0.1 mg |
| mAb anti-Human Factor X, F10-1, 0.1 mg | MO-M40039 | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 237, 0.1 mg | MO-M40040A | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 474, 0.1 mg | MO-M40040B | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, Y8 | MO-M40040D | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 700 | MO-M40040E | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 585 | MO-M40040F | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 8 | MO-M40040H | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 291 | MO-M40040J | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 262 | MO-M40040N | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 71 | MO-M40040Q | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 128 | MO-M40040S | 0.1 mg |
| mAb anti-Staphylococcal Enterotoxin B [SEB], 0.1 mg | MO-M40041 | 0.1 mg |
| mAb anti-Human PTP1-C, PTY6 | MO-M40043A | 0.1 mg |
| mAb anti-Human PTP1-C, PTY11 | MO-M40043B | 0.1 mg |
| mAb anti-Human PTP1-C, PTY15 | MO-M40043D | 0.1 mg |
| mAb anti-Human PTP1-C, PTY10 | MO-M40043E | 0.1 mg |
| mAb anti-Human PTP1-C, PTY13 | MO-M40043F | 0.1 mg |
| mAb anti-human TSH, TSH-2, Detector | MO-M40046A | 0.1 mg |
| mAb anti-human TSH, TSH-1, Capture | MO-M40046B | 0.1 mg |
| mAb anti-Human Prolactin, PRL-1, Capture | MO-M40047B | 0.5 mg |
| mAb anti-Human LH, LH-1, Capture | MO-M40048B | 0.5 mg |
| mAb anti-hCG, HCG-1, Capture | MO-M40049B | 0.5 mg |
| mAb anti-Human FSH, FSH-1, Capture | MO-M40050B | 0.5 mg |
| mAb anti-Human Raf-1, 410 | MO-M40091E | 0.5 mg |
| mAb anti-Human Raf-1, 540 | MO-M40091G | 0.5 mg |
| mAb anti-Human Raf-1, 863 | MO-M40091J | 0.5 mg |
| mAb anti-Human Raf-1, 163 | MO-M40091M | 0.5 mg |
| mAb anti-Human NSE, 145 | MO-M40092A | 0.5 mg |
| mAb anti-Human NSE, 1G6 | MO-M40092B | 0.5 mg |
| mAb anti-Human NSE, 171 | MO-M40092C | 0.5 mg |
| mAb anti-Amyloid β Peptide 42, CA9 3B3 | MO-M40093A | 0.1 mg |
| mAb anti-Amyloid β Peptide 42, CA9 10C11, Detector | MO-M40093B | 0.5 mg |
| mAb anti-Amyloid β Peptide 42, CA9 3F8 | MO-M40093D | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 3F5 | MO-M40094A | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 1H3 | MO-M40094B | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 6C8 | MO-M40094C | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 5B8, Capture | MO-M40094D | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 4A2 | MO-M40094E | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 7H7 | MO-M40094F | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 5A4 | MO-M40094G | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 4B7 | MO-M40094H | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 7G10 | MO-M40094I | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 1F10 | MO-M40094J | 0.5 mg |
| mAb anti-Amyloid β Peptide 40, CV9 7B10, Detector | MO-M40095A | 0.1 mg |
| mAb anti-Amyloid β Peptide 40, CV9 8B2 | MO-M40095B | 0.1 mg |
| mAb anti-Amyloid β Peptide 40, 4B1 | MO-M40095C | 0.1 mg |
| mAb anti-Human α1-antitrypsin, 5G5 | MO-M40096A | 0.1 mg |
| mAb anti-Human α1-antitrypsin, 9F2 | MO-M40096B | 0.1 mg |
| mAb anti-Human α-Synuclein, 4H11 | MO-M40097A | 0.1 mg |
| mAb anti-Human α-Synuclein, 4C1 | MO-M40097B | 0.1 mg |
| mAb anti-Human α-Synuclein, 4B4 | MO-M40097C | 0.1 mg |
| mAb anti-Human α-Synuclein, 8F12 | MO-M40097D | 0.1 mg |
| mAb anti-Human α-Synuclein, 9A9 | MO-M40097E | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, 3E11 | MO-M40098A | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B2B3 | MO-M40098B | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B4H12 | MO-M40098C | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B5B11 | MO-M40098D | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B7B10 | MO-M40098E | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B7H2 | MO-M40098F | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 1A4 | MO-M40099A | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 7G9 | MO-M40099B | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 9B4 | MO-M40099C | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 2A4 | MO-M40099D | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 8E1 | MO-M40100A | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 1G8 | MO-M40100B | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4C1 | MO-M40100C | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 3B12 | MO-M40100D | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H1 | MO-M40100E | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H11 | MO-M40100F | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 5C11 | MO-M40100G | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 10G9 | MO-M40100H | 0.1 mg |
| mAb anti-LCRMP4, 5H5 | MO-M40101A | / |
| mAb anti-LCRMP4, 2H7 | MO-M40101B | / |
| mAb anti-LCRMP4 , 7E1 | MO-M40101C | / |
| mAb anti-Human Phospho-STAT5b [p-Y699], A4B9 | MO-P40001A | 0.1 mg |
| mAb anti-Human Phospho-STAT5b [p-Y699], A2H6 | MO-P40001B | 0.1 mg |
| mAb anti-Human Phospho-ELK-1 [p-S383], B4A12 | MO-P40002A | 0.1 mg |
| mAb anti-Human Phospho-ELK-1 [p-S383], D7H2 | MO-P40002B | 0.1 mg |
| mAb anti-Human Phospho-CREB [p-S133], A3A4 | MO-P40003A | 0.1 mg |
| mAb anti-Human Phospho-CREB [p-S133], B1C4 | MO-P40003B | 0.1 mg |
| mAb anti-Human FPRL-1 C-terminal, C4F9 | MO-P40006A | 0.1 mg |
| mAb anti-Human FPRL-1 C-terminal, B4D9B10 | MO-P40006B | 0.1 mg |
| mAb anti-Human FPRL-1 2nd extracellular loop, 3D7 | MO-P40007A | 0.1 mg |
| mAb anti-Human FPRL-1 2nd extracellular loop, B7H10 | MO-P40007B | 0.1 mg |
| mAb anti-Human Lung Carcinoma, CHALU2 | MO-T40005B | 0.1 mg |
| mAb anti-Human Lung Carcinoma, 3504 | MO-T40005C | 0.1 mg |
| mAb anti-Human Hepatocellular Carcinoma, CHALV1 | MO-T40006A | 0.1 mg |
| mAb anti-Human AFP, AFP-Y2, Detector | MO-T40007A | 0.1 mg |
| mAb anti-Human AFP, AFP-Y1, Capture | MO-T40007B | 0.1 mg |
| mAb anti-Human BPH, YBPH-1 | MO-T40008A | 0.1 mg |
| mAb anti-Human BPH, YBPH-2 | MO-T40008B | 0.1 mg |
| mAb anti-Human PML, B3E9 | MO-T40010A | 0.1 mg |
| mAb anti-Human PML, B4C8 | MO-T40010B | 0.1 mg |
| mAb anti-CA 125, 110 | MO-T40012A | 0.1 mg |
| mAb anti-CA 125, 76 | MO-T40012B | 0.1 mg |
| mAb anti-CA 125, 23 | MO-T40012C | 0.1 mg |
| mAb anti-CA 125, 15 | MO-T40012D | 0.1 mg |
| mAb anti-CA 125 | MO-T40012E | 0.1 mg |
| mAb anti-CA50, 93 | MO-T40014A | 0.1 mg |
| mAb anti-CA50, 826 | MO-T40014B | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,8E2 (Free Sample Available) | MO-T40015A | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9B2 (Free Sample Available) | MO-T40015B | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,1A5 (Free Sample Available) | MO-T40015C | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,4E11 (Free Sample Available) | MO-T40015D | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9E1 (Free Sample Available) | MO-T40015E | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7C4 (Free Sample Available) | MO-T40015F | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7E6 (Free Sample Available) | MO-T40015G | 0.1 mg |
| mAb anti-Human Colorectal Carcinoma, Y94 | MO-T40022 | 0.1 mg |
| mAb anti-Human Colorectal Carcinoma/CD3, BS-1 | MO-T40035 | 0.1 mg |
| mAb anti-Human CEA, CEA-Y2, Detector | MO-T40051A | 0.1 mg |
| mAb anti-Human CEA, CEA-Y1, Capture | MO-T40051B | 0.1 mg |
| mAb anti-Human Free PSA, 103, Detector | MO-T40052A | 0.1 mg |
| mAb anti-Human Free PSA, 108, Capture | MO-T40052B | 0.1 mg |
| mAb anti-Human PSA, CHYH1, Capture | MO-T40081A | 0.1 mg |
| mAb anti-Human PSA, CHYH2, Dectector | MO-T40081B | 0.1 mg |
| mAb anti-Human PMA, YPMA-1 | MO-T40083A | 0.1 mg |
| mAb anti-Human PMA, YPMA-2 | MO-T40083B | 0.1 mg |
| mAb anti-Human PSP, YPSP-1 | MO-T40085A | 0.1 mg |
| mAb anti-Human PSP, YPSP-2 | MO-T40085B | 0.1 mg |
| mAb anti-Human PSP, YPSP-3 | MO-T40085C | 0.1 mg |
| mAb anti-Human PSP, YPSP-4 | MO-T40085D | 0.1 mg |
| mAb anti-Human PSMA, YPSMA-1 | MO-T40086A | 0.1 mg |
| mAb anti-Human PSMA, YPSMA-2 | MO-T40086B | 0.1 mg |
| mAb anti-Human PSMA, 4H11 | MO-T40086C | 0.1 mg |
| mAb anti-Human PSMA, 7F3 | MO-T40086D | 0.1 mg |
| mAb anti-Human PTMA, 8H12 | MO-T40087A | 0.1 mg |
| mAb anti-Human PTMA, 9A10 | MO-T40087B | 0.1 mg |
| mAb anti-Human PTMA, 6A3 | MO-T40087C | 0.1 mg |
| mAb anti-Human PTMA, 4G2 | MO-T40087D | 0.1 mg |
| mAb anti-Human PTMA, 5A10 | MO-T40087E | 0.1 mg |
| mAb anti-Human PTMA, 6H7 | MO-T40087F | 0.1 mg |
| mAb anti-Human PTMA, 1F2, Capture | MO-T40087G | 0.1 mg |
| mAb anti-Human PTMA, 4C3 | MO-T40087H | 0.1 mg |
| mAb anti-Human PTMA, 4A7, Detector | MO-T40087I | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 9A4 | MO-T40088A | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 2E6 | MO-T40088B | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 1A10 | MO-T40088C | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 5C2 | MO-T40088D | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 10H9 | MO-T40088E | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 2A3 | MO-T40088F | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 2E5 | MO-T40088G | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 5H12 | MO-T40088H | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 9C7 | MO-T40088I | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 9D5 | MO-T40088J | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 3E7 | MO-T40088K | 0.1 mg |
| Human PSA ELISA Kit | EL10005 | 96 wells |
| Human IL-8 ELISA Kit | EL10008 | 96 wells |
| Human MCAF / MCP-1 ELISA Kit | EL10009 | 96 wells |
| Human EGF ELISA Kit | EL10010 | 96 wells |
| Human LH ELISA Kit | EL10011 | 96 wells |
| Human TSH ELISA Kit | EL10012 | 96 wells |
| Neonatal TSH ELISA Kit | EL10012N | 96 wells |
| Ultra-Sensitive Human TSH ELISA Kit | EL10012U | 96 wells |
| Human FSH ELISA Kit | EL10013 | 96 wells |
| Human Prolactin ELISA Kit | EL10014 | 96 wells |
| Human SAA ELISA Kit | EL10015 | 96 wells |
| Human SAA ELISA Kit (2nd Generation) | EL10015L | 96 wells |
| Human MCP-3 ELISA Kit | EL10016 | 96 wells |
| Human TNF-α ELISA Kit | EL10019 | 96 wells |
| Human GM-CSF ELISA Kit | EL10020 | 96 wells |
| Human IL-16 ELISA Kit | EL10021 | 96 wells |
| High Sensitivity Human CRP ELISA Kit | EL10022hs | 96 wells |
| Human IL-6 ELISA Kit | EL10023 | 96 wells |
| Human IFN-γ ELISA Kit | EL10024 | 96 wells |
| Human IL-2 ELISA Kit | EL10025 | 96 wells |
| Human IL-4 ELISA Kit | EL10026 | 96 wells |
| Human IL-10 ELISA Kit | EL10027 | 96 wells |
| Human IL-1β ELISA Kit | EL10028 | 96 wells |
| Human TGF-β1 ELISA Kit | EL10029 | 96 wells |
| Human Growth Hormone (hGH) ELISA Kit/Hormone Elisa | EL10030 | 96 wells |
| High Sensitivity Human Growth Hormone (H-hGH) ELISA Kit | EL10030H | 96 wells |
| Human Chorionic Gonadotropin (hCG) ELISA Kit | EL10031 | 96 wells |
| Human IL-12 (P70) ELISA Kit | EL10032 | 96 wells |
| Human IL-2 sRα ELISA Kit | EL10033 | 96 wells |
| Human IL-6 sR ELISA Kit | EL10034 | 96 wells |
| Human IL-5 ELISA Kit | EL10035 | 96 wells |
| HAMA ELISA Kit | EL10036 | 96 wells |
| Human IL-13 Rα2 ELISA Kit | EL10039 | 96 wells |
| Human IL-1α ELISA Kit | EL10040 | 96 wells |
| Human IL-7 ELISA Kit | EL10041 | 96 wells |
| Human IL-11 ELISA Kit | EL10042 | 96 wells |
| Human IL-15 ELISA Kit | EL10044 | 96 wells |
| Human M-CSF ELISA Kit | EL10046 | 96 wells |
| Human TNF-β ELISA Kit | EL10047 | 96 wells |
| Human bFGF ELISA Kit | EL10048 | 96 wells |
| Human Alphafetoprotein (AFP) ELISA Kit | EL10049 | 96 wells |
| Human B2MG ELISA Kit | EL10051 | 96 wells |
| Human Carcinoembryonic Antigen (CEA) ELISA Kit | EL10052 | 96 wells |
| Human IL-17A ELISA Kit | EL10053 | 96 wells |
| Human IL-13 ELISA Kit | EL10054 | 96 wells |
| Human IL-22 ELISA Kit | EL10055 | 96 wells |
| Human IL-9 ELISA Kit | EL10056 | 96 wells |
| Human Amyloid Beta Peptide 42 ELISA Kit | EL10057 | 96 wells |
| Human Programmed Death-Ligand 1 (PD-L1) ELISA Kit | EL10058 | 96 wells |
| Human Programmed Death-1 (PD-1) ELISA Kit | EL10059 | 96 wells |
| Human IL-18 ELISA Kit | EL10060 | 96 wells |
| Multiplex Human Cytokine ELISA Kit (Inflammatory) | EM10001 | 96 wells |
| Multiplex Human Cytokine ELISA Kit (M1/M2/MDSC Cytokines) | EM10002 | 96 wells |
| Multiplex Human Cytokine ELISA Kit (Th1/Th2/Th17) | EM10003 | 96 wells |
| Mouse IL-17A ELISA Kit | MEC1001 | 96 wells |
| Mouse IFN-γ ELISA Kit | MEC1002 | 96 wells |
| Mouse TNF-α ELISA Kit | MEC1003 | 96 wells |
| Mouse GM-CSF ELISA Kit | MEC1004 | 96 wells |
| Mouse MCP-1 ELISA Kit | MEC1005 | 96 wells |
| Mouse IL-2 ELISA Kit | MEC1006 | 96 wells |
| Mouse IL-5 ELISA Kit | MEC1007 | 96 wells |
| Mouse IL-6 ELISA Kit | MEC1008 | 96 wells |
| Mouse IL-4 ELISA Kit | MEC1009 | 96 wells |
| Mouse IL-1β ELISA Kit | MEC1010 | 96 wells |
| Mouse IL-1α ELISA Kit | MEC1011 | 96 wells |
| Mouse TGF-β1 ELISA Kit | MEC1012 | 96 wells |
| pAb anti-Human CRP, Tracer (HRP Labeled) | AI20009P | 0.2 mL |
| mAb anti-Human TNF-α, CH8820, Capture | MO-C40003B | 0.1 mg |
| mAb anti-Human TNF-α, B1E4, Detector | MO-C40003E | 0.1 mg |
| mAb anti-Human TNF-α, B1E4, Tracer (HRP Labeled) | MO-C40003T | 0.2 mL |
| mAb anti-Human TNF-α, B1E4, Tracer (Biotin Labeled) | MO-C40003TB | 0.1 mL |
| mAb anti-Human IL-8, I8-S2, Capture | MO-C40017A | 0.1 mg |
| mAb anti-Human IL-8, I8-60, Detector | MO-C40017D | 0.1 mg |
| mAb anti-Human IL-8, I8-60, Tracer (HRP Labeled) | MO-C40017T | 0.2 mL |
| mAb anti-Human IL-8, I8-60, Tracer (Biotin Labeled) | MO-C40017TB | 0.1 mL |
| mAb anti-Human MCP-1, S14, Capture | MO-C40021B | 0.1 mg |
| mAb anti-Human MCP-1, S101, Detector | MO-C40021D | 0.1 mg |
| mAb anti-Human MCP-1, S101, Tracer (HRP Labeled) | MO-C40021T | 0.2 mL |
| mAb anti-Human MCP-1, S101, Tracer (Biotin Labeled) | MO-C40021TB | 0.1 mL |
| mAb anti-Human SAA, 115, Capture | MO-C40028A | 0.1 mg |
| mAb anti-Human SAA, 607, Detector | MO-C40028E | 0.1 mg |
| mAb anti-Human SAA, 607, Tracer (HRP Labeled), 0.2mL | MO-C40028T | 0.2 mL |
| mAb anti-Human SAA, 607, Tracer (Biotin Labeled), 0.1mL | MO-C40028TB | 0.1 mL |
| mAb anti-Human EGF, S-134, Capture | MO-C40044D | 0.1 mg |
| mAb anti-Human EGF, S-146, Detector | MO-C40044F | 0.1 mg |
| mAb anti-Human EGF, S-146, Tracer (HRP Labeled) | MO-C40044T | 0.2 mL |
| mAb anti-Human EGF, S-146, Tracer (Biotin Labeled) | MO-C40044TB | 0.1 mL |
| mAb anti-Human MCP-3, 113, Detector | MO-C40088A | 0.1 mg |
| mAb anti-Human MCP-3, 542, Capture | MO-C40088G | 0.1 mg |
| mAb anti-Human MCP-3, 113, Tracer (HRP Labeled) | MO-C40088T | 0.2 mL |
| mAb anti-Human MCP-3, 113, Tracer (Biotin Labeled) | MO-C40088TB | 0.1 mL |
| mAb anti-Human IL-16, 323, Detector | MO-C40089J | 0.1 mg |
| mAb anti-Human IL-16, 398, Capture | MO-C40089K | 0.1 mg |
| mAb anti-Human IL-16, 323, Tracer (HRP Labeled) | MO-C40089T | 0.2 mL |
| mAb anti-Human GM-CSF, 59, Capture | MO-C40090B | 0.1 mg |
| mAb anti-Human GM-CSF, 429, Detector | MO-C40090D | 0.1 mg |
| mAb anti-Human GM-CSF, 429, Tracer (HRP Labeled) | MO-C40090T | 0.2 mL |
| mAb anti-Human GM-CSF, 429, Tracer (Biotin Labeled) | MO-C40090TB | 0.1 mL |
| mAb anti Human IL-18 clone 2A10, Capture | MO-C40094A | 0.1mg |
| mAb anti Human IL-18 clone 10H4, Detector | MO-C40094B | 0.1mg |
| mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled) | MO-C40094TB | 0.1 mL |
| mAb anti Human IL-15 clone 5E8, Capture | MO-C40095A | 0.1mg |
| mAb anti Human IL-15 clone B1H6, Detector | MO-C40095B | 0.1mg |
| mAb anti human IL-15 clone B1H6, Tracer (Biotin labeled) | MO-C40095TB | 0.1 mL |
| mAb anti-HIV-1 P24 (Core Protein), 473, Detector | MO-I40002A | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 340, Capture | MO-I40002D2 | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 473, Tracer (HRP), 0.2 mL | MO-I40002T2 | 0.2 mL |
| mAb anti-Human PD-1 / CD279, 7G12, Tracer (Biotin labeled) | MO-L40043TB | 0.1 mL |
| mAb anti Human PD-L1 clone 12B4, Detector | MO-L40044I | 0.1 mg |
| mAb anti Human PD-L1 clone 15G3, Capture | MO-L40044N | 0.1 mg |
| mAb anti human PD-L1 clone 12B4, Tracer (Biotin Labeled) | MO-L40044TB | 0.1 mL |
| mAb anti-hGH, YC6, Capture | MO-M40012A | 0.1 mg |
| mAb anti-hGH, YC8, Tracer (HRP Labeled), 0.2 mL | MO-M40012T | 0.2 mL |
| mAb anti-hGH, YC8, Tracer (Biotin Labeled), 0.1 mL | MO-M40012TB | 0.1 mL |
| mAb anti-Human B2MG, D2E9, Capture | MO-M40021C | 0.1 mg |
| mAb anti-Human B2MG, D3A2, Detector | MO-M40021F | 0.1 mg |
| mAb anti-Human B2MG, D3A2, Tracer (HRP Labeled), 0.2mL | MO-M40021T | 0.2 mL |
| mAb anti-human CRP, 63F4, Capture | MO-M40023A | 0.1 mg |
| mAb anti-human TSH, TSH-2, Detector | MO-M40046A | 0.1 mg |
| mAb anti-human TSH, TSH-1, Capture | MO-M40046B | 0.1 mg |
| mAb anti-human TSH, TSH-2, Tracer (HRP Labeled), 0.2 mL | MO-M40046T | 0.2 mL |
| mAb anti-Human Prolactin, PRL-1, Capture | MO-M40047B | 0.5 mg |
| mAb anti-Human Prolactin, PRL-2, Tracer (HRP Labeled), 0.2 mL | MO-M40047T | 0.2 mL |
| mAb anti-Human LH, LH-1, Capture | MO-M40048B | 0.5 mg |
| mAb anti-Human LH, LH-2, Tracer (HRP Labeled), 0.2 mL | MO-M40048T | 0.2 mL |
| mAb anti-hCG, HCG-1, Capture | MO-M40049B | 0.5 mg |
| mAb anti-hCG, HCG-2, Tracer (HRP Labeled), 0.2 mL | MO-M40049T | 0.2 mL |
| mAb anti-Human FSH, FSH-1, Capture | MO-M40050B | 0.5 mg |
| mAb anti-Human FSH, FSH-2, Tracer (HRP Labeled) | MO-M40050T | 0.2 mL |
| mAb anti-Amyloid β Peptide 42, CA9 10C11, Detector | MO-M40093B | 0.5 mg |
| mAb anti-Amyloid β Peptide 42, CA9 10C11, Tracer (Biotin) | MO-M40093TB | 0.1 mL |
| mAb anti-Amyloid β Peptide N-terminal, NT 5B8, Capture | MO-M40094D | 0.5 mg |
| mAb anti-Amyloid β Peptide 40, CV9 7B10, Detector | MO-M40095A | 0.1 mg |
| mAb anti-Amyloid β Peptide 40, CV9 7B10, Tracer (Biotin) | MO-M40095TB | 0.1 mL |
| mAb anti-Human AFP, AFP-Y2, Detector | MO-T40007A | 0.1 mg |
| mAb anti-Human AFP, AFP-Y1, Capture | MO-T40007B | 0.1 mg |
| mAb anti-Human AFP, AFP-2, Tracer (HRP Labeled), 0.2 mL | MO-T40007T | 0.2 mL |
| mAb anti-Human CEA, CEA-Y2, Detector | MO-T40051A | 0.1 mg |
| mAb anti-Human CEA, CEA-Y1, Capture | MO-T40051B | 0.1 mg |
| mAb anti-Human CEA, CEA-Y2, Tracer (HRP Labeled), 0.2 mL | MO-T40051T | 0.2 mL |
| mAb anti-Human Free PSA, 103, Detector | MO-T40052A | 0.1 mg |
| mAb anti-Human Free PSA, 108, Capture | MO-T40052B | 0.1 mg |
| mAb anti-Human Free PSA, 103, Tracer (HRP Labeled), 0.2 mL | MO-T40052T | 0.2 mL |
| mAb anti-Human PSA, CHYH1, Capture | MO-T40081A | 0.1 mg |
| mAb anti-Human PSA, CHYH2, Dectector | MO-T40081B | 0.1 mg |
| mAb anti-Human PSA, CHYH2, Tracer (HRP Labeled), 0.2 mL | MO-T40081T | 0.2 mL |
| Human Chorionic Gonadotrophin (hCG), 10 mg | AP30002 | 10 mg |
| Human Immunoglobulin G (IgG), 10 mg | IG30001 | 10 mg |
| Mouse Immunoglobulin G (IgG), 10 mg | IG41002 | 10 mg |
| Mouse Immunoglobulin G2b (IgG2b), 10 mg | IG41004 | 10 mg |
| Rat Immunoglobulin G (IgG) | IG42003 | 10 mg |
| Human Umbilical Cord Serum, 10 mL | S30010 | 10 mL |
| ELISA Coating (EC) Stabilizer, 500 mL | S7001 | 500 mL |
| Human IL-8 Matched Antibody Pair for ELISpot | SL10008A | 5 × 96 wells |
| Human IL-8 Development Set for ELISpot | SL10008B | 5 × 96 wells |
| Human IL-8 ELISpot Kit | SL10008E | 6 X 96 wells |
| Human MCAF (MCP-1) Matched Antibody Pair for ELISpot | SL10009A | 5 × 96 wells |
| Human MCAF (MCP-1) Development Set for ELISpot | SL10009B | 5 × 96 wells |
| Human MCAF (MCP-1) ELISpot Kit | SL10009E | 6 X 96 wells |
| Human GM-CSF Matched Antibody Pair for ELISpot | SL10020A | 5 × 96 wells |
| Human GM-CSF Development Set for ELISpot | SL10020B | 5 × 96 wells |
| Human GM-CSF ELISpot Kit | SL10020E | 6 X 96 wells |
| Human IFN-γ Matched Antibody Pair for ELISpot | SL10024A | 5 × 96 wells |
| Human IFN-γ Development Set for ELISpot | SL10024B | 5 × 96 wells |
| Human IFN-γ ELISpot Kit | SL10024E | 6 X 96 wells |
| Human IL-12 (P70) ELISpot Kit | SL10032E | 6 X 96 wells |
| TMB Solution (500 mL Part A & 500 mL Part B) | SU6006 | 1.0 L |
| pAb Rabbit anti-HCV Virus, 1.0 mg | AI20006P | 1.0 mg |
| pAb Rabbit anti-HIV-1 p24, 1.0 mg | AI20008P | 1.0 mg |
| pAb anti-Human CRP, Tracer (HRP Labeled) | AI20009P | 0.2 mL |
| pAb Rabbit anti-Mouse IgG , 1.0 mg | AI50005 | 1.0 mg |
| pAb Rabbit anti-Mouse IgG - HRP Conjugated, 1.0 mL | AI50005P | 1.0 mL |
| pAb Rabbit anti-hGH, | AI50006P | 1.0 mg |
| pAb Chicken anti-human IL-8 (IgY fraction) | AI60001 | 1.0 mg |
| pAb Rabbit anti-Human FPRL-1 2nd Extracellular Loop | AI70001A | 0.1 mg |
| pAb Rabbit anti-Human FPRL-1 C-terminal | AI70001B | 0.1 mg |
| pAb Rabbit anti-Human PML [Ring Finger Domain] | AI70002A | 0.1 mg |
| pAb Rabbit anti-Human PML [B-box 1 domain] | AI70002B | 0.1 mg |
| pAb Rabbit anti-Bcl-2 | AI70003A | 0.1 mg |
| pAb Rabbit anti-Phospho-Bcl-2 (Thr56) | AI70003B | 0.1 mg |
| pAb Rabbit anti-Phospho-Bcl-xL (Thr115) | AI70003D | 0.1 mg |
| pAb Rabbit anti-Phospho c-kit (Tyr719) | AI70004A | 0.1 mg |
| pAb Rabbit anti-Phospho IKK-γ (Ser31) | AI70005A | 0.1 mg |
| pAb Rabbit anti-NF-κB-p65 (RelA) | AI70006A | 0.1 mg |
| pAb Rabbit anti-Phospho-NF-қB-p65 (Ser276) | AI70007A | 0.1 mg |
| pAb Rabbit anti-Phospho-NF-қB-p65 (Ser468) | AI70008A | 0.1 mg |
| pAb Rabbit anti-Phospho NF-қB-p105/p50 (Ser337) | AI70009A | 0.1 mg |
| pAb Rabbit anti-Human Serum Albumin (HSA) | AI80001 | 0.1 mg |
| pAb Rabbit anti-Human Fibrinogen, 0.1 mg | AI80002 | 0.1 mg |
| pAb Rabbit anti-Human Transferrin | AI80003 | 0.1 mg |
| pAb Rabbit anti-Human IgA, 0.5 mg | AI80004 | 0.5 mg |
| pAb Rabbit anti-human IgM, 0.5 mg | AI80005 | 0.5 mg |
| pAb Rabbit anti-Human TREK-1 (K2p2.1) | AI80006A | 0.1 mg |
| pAb Rabbit anti-Mouse Kchip1 | AI80007 | 0.1 mg |
| pAb Rabbit anti-Mouse Kchip4 | AI80008 | 0.1 mg |
| pAb Rabbit anti-Mouse Kv4.3 | AI80010A | 0.1 mg |
| pAb Rabbit anti-Mouse TRPV1 | AI80011A | 0.1 mg |
| pAb Rabbit anti-Mouse TRPV3 | AI80012A | 0.1 mg |
| pAb Rabbit anti-Human JAK2 | AI80013A | 0.1 mg |
| pAb Rabbit anti-Human Glutathione S Transferase (GST), 0.1 mg | AI80014 | 0.1 mg |
| pAb Rabbit anti-Human Amyloid beta peptide 42 | AI90001 | 0.1 mg |
| pAb Rabbit anti-Human Amyloid beta peptide 43 | AI90002 | 0.1 mg |
艾美捷科技代理Prolume品牌。
Prolume Ltd. 由 Bruce Bryan 博士及其团队创立，专注于生物发光技术的研究与开发。公司通过其子公司 NanoLight® Technologies 提供广泛的生物发光试剂和报告系统，服务于制药、农业化学品和研究产品行业。Prolume的3种来自海洋刺胞动物（Renilla mulleri、Renilla reniformis和Ptilosarcus）的绿色荧光蛋白（GFP）在本质上比市场上任何其他GFP都更亮，包括著名的Aequorea GFP中最亮的变体。Prolume的GFP在多种领域具有许多潜在用途，如药物发现和生物医学研究；高通量筛选（HTS）；荧光激活细胞分选（FACS）；转基因报告细胞、动物和植物中的基因表达；环境和过程监测；以及许多蛋白质组学应用，包括蛋白质生物芯片，以及使用FRET或BRET动态监测蛋白质相互作用。Prolume 目前正在开发一种具有专利权的桡足类发光酶（Gaussia princeps），这种酶非常明亮、体积小且生化性能强大。Prolume 还大量合成 Coelenterazine，这是光蛋白 Aequorin 和许多发光酶（包括 Renilla reniformis 和 Gaussia 的酶）天然使用的荧光素。
Life Diagnostics公司专注于研发和生产临床前研究以及动物医学诊断相关的ELISA试剂盒、纯化的生物标志物和抗体等产品。产品覆盖心血管疾病、急性期反应、免疫毒性和免疫学标志物等研究领域，主要应用于小鼠、大鼠、兔、猫、狗、猪、猴和鸡等物种。此外，鉴于越来越多的研究围绕聚乙二醇化（PEGylated）生物制剂，Life Diagnostics公司也开发出了抗体PEG单克隆抗体和ELISA试剂盒用于检测PEG以及PEG化的蛋白。
Life Diagnostics manufactures ELISA kits, SPARCL™ kits, purified biomarkers and antibodies for preclinical research and veterinary diagnostics. Our areas of expertise include cardiovascular, acute phase, immunotoxicity and immunology biomarkers in species including mouse, rat, rabbit, cat, dog, pig, cow, monkey and chicken. Because of the increasing research into PEGylated biologics we have also developed anti-PEG monoclonal antibodies and ELISA kits for detection of PEG, mPEGylated proteins and anti-PEG antibodies. We manufacture all of the products listed on our website.
Life Diagnotics目前可提供用于检测骨骼肌肌钙蛋白-I(troponin-I)、肌红蛋白(myoglobin)、脂肪酸结合蛋白(fatty acid binding protein, FABP)以及肌球蛋白轻链(myosin light chain-1, MLC-1)等代表性标志分子的ELISA试剂盒；主要提供针对检测小鼠、大鼠、兔、狗、猪和猴等种属的检测试剂盒。与肌红蛋白蛋白和心脏型FABP不同，骨骼肌肌钙蛋白I特异性表达于骨骼肌细胞，因此为检测肌肉损伤的首选标志物分子。
Life Diagnotics生产的PEG试剂主要包括抗体、ELISA试剂盒以及PE化蛋白。
（1）PEG抗体
（2）PEG ELISA试剂盒：竞争法ELISA检测PEG化蛋白(含甲氧基，或不含甲氧基)；夹心法ELISA快速检测甲氧基PEG(mPEG)和mPEG化蛋白；抗PEG IgG和IgM ELISA试剂盒用于检测小鼠、大鼠和猴血清或血浆中PEG抗体的水平。
（3）PEG化蛋白
此外，Life Diagnostics还提供PEG包被的微孔板和封闭缓冲液，专门设计用于免疫检测PEG或PEG化抗体。大多数商业化的ELISA试剂盒含有去垢剂如Tween-20(一种含有PEG的去垢剂)会干扰PEG的检测。Life Diagnostics公司提供的封闭缓冲液不含去垢剂和PEG, 可用于稳定包被有PEG或PEG抗体的平板。
Life Diagnostics除提供多种心肌标志物ELISA检测试剂盒之外，还生产多种纯化的心肌生物标志物蛋白，包括肌钙蛋白I、肌钙蛋白T、肌钙蛋白复合物、肌红蛋白和脂肪酸结合蛋白等，可提供来自不同物种包括人、小鼠、大鼠、豚鼠、兔、狗、猪、牛和猴的蛋白。
主要产品包括：
SPARCL Kits
Acute Phase Rgts. »
Cardiac Biomarkers »
Immunoglobulin Rgts. »
Immunotoxicity ELISA Kits
PEG Reagents »
Skeletal Muscle Rgts. »
Liver Biomarkers
Misc Biomarkers
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://gropep.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Life Diagnostics"> Life Diagnostics
艾美捷科技代理HycultBiotech全系列产品。
Hycult Biotech是一家专注于设计、研发、生产以及销售抗体和其相关产品的公司，其特色产品是天然免疫及相关领域的免疫分析试剂，例如补体， 嗜中性粒细胞蛋白，TLP，清道夫受体以及急性期蛋白等。除此之外，Hycult Biotech公司也可以提供炎症反应和细胞损伤等方面的产品。
HYCULT BIOTECH的主要产品包括：
Assays
Monoclonal antibodies
Polyclonal antibodies
Disease state human plasma
Proteins
Functional study antibodies
Immunoassay antibodies
Secondary reagents
按照产品领域细分：
Acute phase proteins
Adhesion molecules
Antimicrobial peptides
Cell damage and toxicity
Coagulation molecules
Complement and collectins
Cytokines and chemokines
Granulocyte and lymphocyte proteins
LPS and microbial toxins
Oxidative stress
TLR and inflammasome
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
< " data-original="http://gropep.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Hycult Biotech"> Hycult Biotech
DiaMetra公司位于意大利Perugia，致力于为诊断行业提供高品质产品，包括标品和检测试剂盒，涉及的检测领域包括：唾液试剂盒、高血压及钙的代谢、自体免疫疾病、糖尿病指标检测、肿瘤标志物、固醇类激素、性激素、甲状腺激素检测等。
Diametra is dedicated to providing quality products and the highest level of service in its target diagnostics segments. Through innovation and total commitment we strive to create value for our people, our customers and for the shareholders.
As an organization we constantly strive for innovation, not simply in the products we bring to the market but also in the way we interact with our customers and with each other. This is grounded in our solution driven approach to partnership.
产品主要应用领域：
Saliva kits
Hypertension / Calcium Metabolism
Controls
Autoimmune Diseases
Diabetes Monitoring
Tumor Markers
Steroids Hormones
Fertility Proteic Hormones
Thyroid Monitoring
Circulating Immuno Complexes
Miscellaneous
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
艾美捷科技代理IBA Lifesciences品牌。
IBA Lifesciences GmbH拥有专利性的Strep-tag技术，开发了一些列用于细胞和蛋白分离的高性能研究工具。IBA Lifesciences GmbH产品包括纯化、分析、克隆&表达，以及定制解决方案。
Strep-tag®系统可以提供各种标签-配体组合，以便实现广泛的分析应用：
（1）蛋白质纯化：亲和层析、高通量纯化、Pull-Down、磁珠纯化、预装柱、FPLC柱、树脂等；
（2）蛋白质分析：表面等离子体共振（SPR）、生物层干涉测量（BLI）、酶联免疫吸附测定（ELISA）、蛋白质印迹和流式细胞术（FACS）；
（3）单克隆抗体开发与生产；
（4）克隆和表达：基于StarGate系统构建的多种不同的表达载体。
< " data-original="http://gropep.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理IBA Lifesciences品牌"> 艾美捷科技代理IBA Lifesciences品牌
<艾美捷科技有限公司授权代理Katchem公司全系列产品。
产品详情请见艾美捷科技丁香通商铺或直接咨询客服人员。
https://vicbio.biomart.cn/supply/c_307368.htm
Katchem公司，位于捷克共和国Prague，是一家主要生产硼化学产品的公司，其产品主要包括：硼酸盐和碳硼酸盐簇、十硼烷（14）簇、碳硼烷、COSANes、金属硼氢化物、硼砂及其衍生物、硼烷-路易斯碱配合物、硼酸和酯、BNCT用化合物、非硼化合物、二氨基甲酸盐和催化系统等。
【产品应用场景1】
中子治疗，硼中子俘获治疗（Boron Neutron Capture Therapy，简称BNCT）。
BNCT的原理是利用发生在肿瘤细胞内的核反应摧毁癌细胞，由于同时需要中子源和B，因此，是一种二元化治疗肿瘤的新方法。BNCT的基本过程分为两部分：首先在肿瘤细胞内聚积足够量的稳定性核素B，即将一种含B的化合物引入患者体内，这种化合物与肿瘤细胞有很强的亲和力，进入体内后，迅速聚集于肿瘤细胞内，而在其它正常组织中分布很少；然后再用中子束照射肿瘤部位，使中子与肿瘤细胞内聚集的B发生B（n,α）Li核反应，B俘获中子后，形成同位素B，B迅速分裂为重粒子Li和α，肿瘤细胞被α射线和Li照射而死亡。适用于硼中子捕获治疗的含硼化合物应具备四个重要特性：对人体毒性低、对正常细胞的亲和性低、对癌细胞的亲和性高（最好可达正常细胞的3倍以上，且每克癌细胞分布的硼达到20微克以上）、能被人体迅速从正常细胞和血液移除。目前仅有两种含硼化合物应用在临床试验：Sodium Borocaptate (BSH)以及Boronophenylalanine(BPA)。
【产品应用场景2】
电池研发。
【热销产品】
【产品列表】
| 产品编码 | 产品名称 | CAS号 | 规格（g） |
| 410 | Sodium triborate dioxane | CAS [33220-35-8] | 1、5、10、25、50 |
| 458 | Cesium triborate | CAS [12007-45-3] | 1、5、10 |
| 564 | LIthium triborate dioxane | CAS [212697-88-6] | 1、5、10 |
| 315 | Triethylammonium decahydrodecaborate | CAS [12075-73-9] | 5、10、25、50、100 |
| 333 | Tetramethylammonium decahydrodecaborate | CAS [12073-87-9] | 5、10、25、50、100 |
| 493 | Sodium decahydrodecaborate | CAS [12294-20-1] | 5、10、25、50、100 |
| 459 | Ammonium decahydrodecaborate | CAS [12008-61-6] | 5、10、25、50、100 |
| 229 | Potassium decahydrodecaborate | CAS [12447-89-1] | 5、10、25、50、100 |
| 246 | Cesium decahydrodecaborate | CAS [12008-58-1] | 10、25、50、100 |
| 675 | Lithium decahydrodecaborate, trihydrate | CAS [64719-89-7 anhyd] | 5、10、25 |
| 812 | Calcium decahydrodecaborate, trihydrate | CAS [64719-84-2 anhyd] | 5、10、25 |
| 804 | Cesium decachlorodecaborate | CAS [12360-16-6] | 5、10、25、50 |
| 805 | Cesium decabromodecaborate | CAS [12356-10-4] | 5、10、25、50 |
| 803 | Cesium decaiododecaborate | CAS [88423-95-4] | 5、10、25、50 |
| 324 | Cesium tetradecahydroundecaborate | CAS [12008-72-9] | 5、10、25、50、100 |
| 453 | Triethylammonium tetradecahydroundecaborate | CAS [12106-44-4] | 5、10、25、50、100 |
| 614 | Potassium tetradecahydroundecaborate | CAS [52261-21-9] | 5、10、25、50、100 |
| 615 | Sodium tetradecahydroundecaborate | CAS [52261-23-1] | 5、10、25、50、100 |
| 372 | Trimethylammonium tetradecahydroundecaborate | CAS [12076-74-3] | 5、10、25、50、100 |
| 684 | Lithium tetradecahydroundecaborate, trihydrate | CAS [52261-22-0 anhyd.] | 1、5、10 |
| 815 | Calcium tetradecahydroundecaborate, dihydrate | 1、5、10 | |
| 290 | Triethylammonium dodecahydrododecaborate | CAS [12551-42-7] | 5、10、25、50、100、250、1000 |
| 316 | Cesium dodecahydrododecaborate | CAS [12008-75-2] | 5、10、25、50、100、250、1000 |
| 228 | Potassium dodecahydrododecaborate | CAS [12008-77-4] | 5、10、25、50、100、250、1000 |
| 257 | Sodium dodecahydrododecaborate | CAS [12008-78-5] | 5、10、25、50、100、250、1000 |
| 328 | Sodium dodecahydrododecaborate anhydrous, <0.1% water | CAS [12008-78-5] | 5、10、25、50、100、250 |
| 569 | Lithium dodecahydrododecaborate, tetrahydrate | CAS [1166383-94-3] | 5、10、25、50、100、250、1000 |
| 445 | Magnesium dodecahydrododecaborate, tetrahydrate | CAS [53572-04-6 anhyd.] | 5、10、25 |
| 446 | Cobalt dodecahydrododecaborate, dihydrate | ||
| 597 | Calcium dodecahydrododecaborate monohydrate | CAS [90157-87-2 anhyd.] | 5、10、25 |
| 492 | Rubidium dodecahydrododecaborate | CAS [12598-46-8] | 5、10、25 |
| 243 | Sodium dodecachlorododecaborate | CAS [111637-82-2] | 5、10、25、100 |
| 244 | Sodium dodecabromododecaborate | CAS [1253735-09-9] | 5、10、25、100 |
| 550 | Sodium dodecaiodododecaborate | CAS [149211-37-0] | 5、10、25、100 |
| 544 | Sodium hydroxydodecaborate | CAS [56189-13-0] | 1、5、10 |
| 347 | Cesium dodecahydroxydodecaborate | CAS [12589-26-3] | 1、5、10、50 |
| 211 | Sodium mercaptododecaborate, N-BSH | CAS [144885-51-8] | 1、5、10、25、50 |
| 266 | Cesium mercaptododecaborate, N-BSH | CAS [12448-23-6] | 1、5、10、25、50 |
| 587 | Tetramethylammonium mercaptododecaborate, N-BSH | CAS [135274-62-3] | 1、5、10、25、50 |
| 489 | syn -Octadecaborane(22) | CAS No. [21107-45-9] | 1、5、10 |
| 488 | anti -Octadecaborane(22) | CAS No. [21107-56-2] | 1、5、10 |
| 359 | Mixture of syn - and anti -octadecaboranes(22) | 1、5、10、20 | |
| 414 | Triethylammonium decahydrodecaborate 10B | ||
| 556 | Sodium decahydrodecaborate 10B, GB-10 | CAS [12373-10-3] | 1、5、10、25 |
| 258 | Triethylammonium dodecahydrododecaborate 10B | 1、10、25、50 | |
| 226 | Sodium dodecahydrododecaborate 10B | CAS [109851-98-1] | 1、10、25、50 |
| 588 | Cesium dodecahydrododecaborate 10B | CAS [109788-95-6] | 1、10、25、50 |
| 500 | Lithium dodecahydrododecaborate 10B, tetrahydrate | CAS [51745-90-5 anhyd.] | 1、10、25、50 |
| 210 | Sodium mercaptododecaborate 10B, BSH | CAS [12448-24-7] | 1、5、10、50 |
| 603 | Tetramethylammonium mercaptododecaborate 10B | CAS [130207-66-8] | 1、5、10、50 |
| 401 | Cesium mercaptododecaborate 10B | CAS [109742-44-1] | 1、5、10、50 |
| 486 | Triethylammonium dodecahydrododecaborate 11B | 1、10、25、50 | |
| 491 | Sodium dodecahydrododecaborate 11B | 1、5、10 | |
| 466 | Cesium dodecahydrododecaborate 11B | CAS [1347742-49-7] | 1、5、10 |
| 485 | Rubidium dodecahydrododecaborate 11B | CAS [1347742-48-6] | 1、2、5、10 |
| 450 | Sodium mercaptododecaborate 11B | CAS [459142-76-8] | 1、5、10 |
| 457 | Cesium carbaundecaborate | CAS [51391-30-1] | 1、5、10、25、50、100、250 |
| 456 | 7-Amino-7-carbaundecaborate | CAS [12373-10-3] | 1、5、10、25、50、100 |
| 264 | 7-Trimethylamino-7-carbaundecaborate | CAS [31117-16-5] | 1、5、10、25、50、100、250 |
| 676 | Sodium carbaundecaborate | CAS [68084-95-7] | 1、5、10 |
| 677 | Lithium carbaundecaborate, hemihydrate | CAS [2169943-32-0] | 1、5、10 |
| 251 | 1-Amino-1-carbadodecaborate | CAS [749831-19-4] | 1、5 |
| 252 | 1-Trimethylamine-1-carbadodecaborane | CAS [92468-34-3] | 1、5 |
| 212 | Trimethylammonium carbadodecaborate | CAS No.[108608-25-9] | 1、5、10、20、50 |
| 213 | Cesium carbadodecaborate | CAS No.[12539-26-3] | 1、5、10、20、50 |
| 421 | Triethylammonium carbadodecaborate | CAS No.[223548-06-9] | 1、5、10、20、50 |
| 242 | Potassium carbadodecaborate | CAS No.[92468-39-8] | 1、5、10、20、50 |
| 647 | Sodium carbadodecaborate | CAS No.[92468-38-7] | 1、5、10、20、50 |
| 648 | Lithium carbadodecaborate hemihydrate | CAS No.[92468-37-6 anhyd.] | 1、5、10、20、50 |
| 813 | Calcium carbadodecaborate trihydrate | CAS No.[2077150-90-2 anhyd.] | 1、5、10、20、50 |
| 523 | Cesium 1-methyl-1-carbadodecaborate new | CAS No.[176099-40-4] | 1、5、10 |
| 349 | Trimethylammonium 1-propyl-1-carbadodecaborate new | 1、5、10 | |
| 351 | Trimethylammonium 1-mercapto-1-carbadodecaborate new | 1、5、10 | |
| 365 | Trimethylammonium 1-hydroxy-1-carbadodecaborate new | CAS No.[2077207-91-9] | 1、5、10 |
| 366 | Trimethylammonium 1-carboxy-1-carbadodecaborate new | CAS No.[1252604-78-6] | 1、5、10 |
| 378 | Cesium closo -1-carbadecaborate | CAS No.[12539-20-7] | 1、5、10 |
| 649 | Sodium closo -1-carbadecaborate | CAS No.[94322-26-6] | 1、5、10 |
| 650 | Lithium closo -1-carbadecaborate, hydrate | CAS No.[94322-25-5 anhyd.] | 1、5、10 |
| 814 | Calcium closo -1-carbadecaborate, dihydrate | 1、5、10 | |
| 412 | Trimethylammonium 7,8-dicarbaundecaborate | CAS No.[12543-22-5] | 1、5、10、25、50、100 |
| 613 | Cesium 7,8-dicarbaundecaborate | CAS No.[63748-65-2] | 1、5、10、25、50、100 |
| 673 | Sodium 7,8-dicarbaundecaborate | CAS No.[12602-34-5] | 1、5、10、25、50、100 |
| 682 | Lithium 7,8-dicarbaundecaborate dihydrate | CAS No.[1629094-87-6 anhyd.] | 1、5、10、25、50、100 |
| 214 | Trimethylammonium 7-methyl-7,8-dicarbaundecaborate | 1、5、10、25、50 | |
| 495 | Trimethylammonium 7,9-dicarbaundecaborate | CAS No.[54531-56-5] | 1、5、10、25、50、100 |
| 384 | Cesium 7,9-dicarbaundecaborate | CAS No.[12305-33-8] | 1、5、10、25、50、100 |
| 674 | Sodium 7,9-dicarbaundecaborate | 1、5、10、25、50、100 | |
| 683 | Lithium 7,9-dicarbaundecaborate trihydrate | CAS No.[1629094-86-5 anhyd.] | 1、5、10、25、50、100 |
| 208 | Decaborane(14) | CAS [17702-41-9] | 1、5、10、25、50、100、250 |
| 419 | Bis(acetonitrile)-decabora | CAS [28377-97-1] | 5、20、100、250 |
| 238 | Bis(dimethylsulfide)-decaborane | CAS [28377-92-6] | 5、20、100、250 |
| 204 | Decaborane(14) 10B(Isotopic enrichment: 10B >99.5%) | CAS [488806-75-3] | 1、5、10、25 |
| 301 | Decaborane(14) 11B(Isotopic enrichment: 11B >99.8%) | CAS [94601-45-3] | 1、5、10、25 |
| 199 | o -Carborane | CAS No. [16872-09-6] | 1、5、10、25、50、100、250、500 |
| 209 | 1-Methyl-o -carborane | CAS No. [16872-10-9] | 5、10、25、50、100 |
| 233 | 1-Bromomethyl-o -carborane | CAS No. [19496-84-5] | 5、10、25、50、100 |
| 269 | 1,2-Dimethyl-o -carborane | CAS No. [17032-21-2] | 1、5、10 |
| 332 | 1-n-Propyl-o -carborane | CAS No. [23940-16-1] | 1、5、10 |
| 463 | 1-Hexyl-o -carborane | CAS No. [20740-05-0] | 1、5、10、25、50、100 |
| 464 | 1,2-Dihexyl-o -carborane | CAS No. [280762-92-7] | 1、5、10、25、50 |
| 203 | 1-Phenyl-o -carborane | CAS No. [16390-61-7] | 1、5、10、25、50、100 |
| 465 | 1,2-Didodecyl-o -carboran | CAS No. [943026-62-8] | 1、5、10、25、50 |
| 609 | 1-Methyl-2-propargyl-o -carborane | CAS No. [23868-57-7] | 1、2、5 |
| 318 | 1-Hydroxymetyl-o -carborane | CAS No. [19610-34-5] | 1、5、10 |
| 448 | 1,2-Bis(hydroxymethyl)-o -carborane | CAS No. [19610-37-8] | 1、5、10 |
| 297 | o -Carborane-1-carboxylic acid | CAS No. [18178-04-6] | 1、5、10 |
| 253 | o -Carborane-1,2-dicarboxylic acid | CAS No. [23835-80-5] | 1、5、10 |
| 480 | 1-Trimethylsilyl-o -carborane | CAS No. [18971-67-0] | 1、5、10、25 |
| 516 | 1-Hydroxy-o -carborane | CAS No. [23987-99-7] | 1、2、5、10 |
| 502 | 1,2-Dihydroxy-o -carboran | CAS No. [868382-62-1] | 1、2、5、10 |
| 293 | 1-Mercapto-o -carborane | CAS No. [17526-07-7] | 1、5、10、25 |
| 232 | 1,2-Dimercapto-o -carbora | CAS No. [23810-63-1] | 1、5、10、25 |
| 345 | 9-Iodo-o -carborane | CAS No. [17830-03-4] | 5、10、20 |
| 346 | 9,12-Diiodo-o -carborane | CAS No. [17702-35-1] | 5、10、20 |
| 240 | 9-Mercapto-o -carborane | CAS No. [64493-43-2] | 1、5、10 |
| 433 | 9,12-Dimercapto-o -carborane | CAS No. [75572-47-3] | 1、2、5 |
| 440 | 8,9,12-Trimercapto-o -carborane | CAS No. [1423066-18-5] | 1、2、5 |
| 200 | m -Carborane | CAS No. [16986-24-6] | 1、5、10、25、50、100、250 |
| 518 | 1-Methyl-m -carborane | CAS No. [17378-55-1] | 1、5、10、25 |
| 317 | 1-Allyl-7-methyl-m -carbor | CAS No. [20670-09-1] | 1、5、10、25 |
| 319 | 1,7-Diallyl-m -carborane | CAS No. [1232168-57-8] | 1、5、10、25 |
| 320 | 1,7-Bis(hydroxymethyl)-m -carborane | CAS No. [23924-78-9] | 1、5、10、50 |
| 298 | m -Carborane-1-carboxylic acid | CAS No. [18581-81-2] | 1、5、10 |
| 261 | 1,7-Bis(chlordimethylsilyl)-m -carborane | CAS No. [16996-48-8] | 1、5、10、50、100、250 |
| 259 | 1,7-Bis(methoxydimethylsilyl)-m -carborane | CAS No. [17631-41-3] | 1、5、10、50、100、250 |
| 321 | 1,7-Bis(hydroxydimethylsilyl)-m -carborane | CAS No. [22742-19-4] | 1、5、10、50、100、250 |
| 481 | 1-Vinyldimethylsilyl-m -carborane | 1、5、10、25 | |
| 501 | 1,7-Bis(vinyltetramethyldisiloxy)-m -carborane | CAS No. [210707-88-3] | 1、5、10、25、50 |
| 527 | 1-Hydroxy-m -carborane | CAS No. [23988-02-5] | 1、5、10 |
| 532 | 1,7-Dihydroxy-m -carbora | CAS No. [55629-26-0] | 1、5、10 |
| 496 | 1-Mercapto-m -carborane | CAS No. [56310-80-6] | 1、2、5、10 |
| 434 | 1,7-Dimercapto-m -carborane | CAS No. [23810-64-2] | 1、2、5、10 |
| 513 | 9-Mercapto-m -carborane | CAS No. [64493-44-3] | 1、2、5、10 |
| 201 | p -Carborane | CAS No. [20644-12-6] | 1、5、10、25、50 |
| 267 | p -Carborane-1,12-dicarboxylic acid | CAS No. [23087-99-2] | 1、5、10 |
| 528 | 1-Hydroxy-p -carborane | CAS No. [54360-43-9] | 1、5、10 |
| 533 | 1,12-Dihydroxy-p -carbora | CAS No. [55629-27-1] | 1、5、10 |
| 497 | 1-Mercapto-p -carborane | CAS No. [69985-41-7] | 1、2、5、10 |
| 498 | 1,12-Dimercapto-p -carborane | CAS No. [24228-77-1] | 1、2、5、10 |
| 341 | 4,5-Dicarba-arachno -nonaborane(13) new | CAS No. [113678-30-1] | 5、10、25 |
| 339 | 4,6-Dicarba-arachno -nonaborane(13) new | CAS No. [17653-38-2] | 5、10、25 |
| 340 | 6,9-Dicarba-arachno -decaborane(14) new | 5、10、25 | |
| 227 | 5,6-Dicarba-nido -decaborane(12) | CAS No. [41655-26-9] | 5、10、20 |
| 539 | Ten-vertex-o -carborane | CAS No. [41655-27-0] | 2、5 |
| 354 | Ten-vertex-m -carborane | CAS No. [23704-81-6] | 2、5 |
| 255 | Ten-vertex-p -carborane | CAS No. [23653-12-6] | 2、5 |
| 206 | o -Carborane 10B | CAS No. [760207-79-2] | 1、5、10 |
| 207 | 1-Methyl-o -carborane 10B | CAS No. [1177403-84-7] | 1、5、10 |
| 205 | m -Carborane 10B | 1、5、10 | |
| 595 | o -Carborane 11B | CAS No. [1291083-31-2] | 1、5、10 |
| 407 | m -Carborane 11B | CAS No. [1291083-36-7] | 1、5、10 |
| 271 | COSAN | CAS No.[60146-18-1] | 1、5、10、25、50、100、250 |
| 218 | Chloro-protected cesium bis(1,2-dicarbollide)-cobaltate | CAS No.[84913-29-1] | 1、5、10、25、50、100、250 |
| 393 | Bromo-protected cesium bis(1,2-dicarbollide)-cobaltate | CAS No.[84933-24-4] | 1、5、10、50 |
| 292 | COSAN dioxanate | CAS No.[188478-29-7] | 1、2、5、10、50 |
| 476 | NISAN | CAS No.[36548-55-7] | 1、5、10、25、50 |
| 483 | FESAN | CAS No.[12304-97-1] | 1、5、10、25、50 |
| 520 | Lithium COSAN | CAS No.[167568-99-2] | 1、5 |
| 517 | Sodium COSAN | CAS No.[99492-72-5] | 1、5 |
| 392 | Sodium borohydride | CAS [16940-66-2] | 50、100、250、500、1000 |
| 429 | Rubidium borohydride | CAS [20346-99-0] | 1、2、5、10 |
| 225 | Cesium borohydride | CAS [19193-36-3] | 1、2、5、10 |
| 596 | Calcium borohydride | CAS [17068-95-0] | 1、5、10、25 |
| 636 | Magnesium borohydride | CAS [16903-37-0] | 1、5、10、25 |
| 263 | Lithium borodeuteride | CAS [15246-28-3] | 1、2、5、10 |
| 361 | Lithium borohydride 10B | 1、2、5、10 | |
| 362 | Lithium borodeuteride 10B | 1、2、5、10 | |
| 323 | Lithium borohydride 11B | 1、2、5、10 | |
| 239 | Lithium borodeuteride 11B | CAS [1242073-72-8] | 1、2、5、10 |
| 363 | Lithium borohydride 7Li | 1、2、5、10 | |
| 367 | Lithium borodeuteride 7Li | 1、2、5、10 | |
| 370 | Lithium borohydride 7Li, 10B | CAS [139980-21-5] | 1、2、5、10 |
| 371 | Lithium borodeuteride 7Li, 10B | CAS [163779-14-4] | 1、2、5、10 |
| 442 | Lithium borohydride 7Li, 11B | CAS [139980-20-4] | 2、5 |
| 499 | Lithium borodeuteride 7Li,11B | CAS [163779-13-3] | 1、2、5、10 |
| 326 | Sodium borodeuteride | CAS [15681-89-7] | 5、10 |
| 202 | Sodium borohyride 10B | CAS [72901-47-4] | 1、2、5、10 |
| 373 | Sodium borodeuteride 10B | CAS [163779-18-8] | 1、2、5、10 |
| 396 | Sodium borohyride 11B | CAS [72901-46-3] | 1、2、5、10 |
| 397 | Sodium borodeuteride 11B | CAS [163779-17-7] | 1、2、5、10 |
| 379 | Potassium borodeuteride | CAS [17440-13-0] | 5、10 |
| 455 | Potassium borohyride 10B | 1、2、5、10 | |
| 417 | Potassium borodeuteride 10B | 1、2、5、10 | |
| 447 | Potassium borohyride 11B | CAS [1417734-35-0] | 1、2、5、10 |
| 413 | Potassium borodeuteride 11B | 1、2、5、10 | |
| 508 | Calcium borodeuteride | CAS [122042-59-5] | 1、2、5、10 |
| 352 | Calcium borohydride 10B | 1、2、5、10 | |
| 355 | Calcium borohydride 11B | 1、2、5、10 | |
| 220 | Calcium borodeuteride 11B | CAS [1309461-44-6] | 1、2、5、10 |
| 656 | Magnesium borohydride 11B | 1、2、5、10 | |
| 452 | Cesium borohydride 11B | CAS [1417734-38-3] | 1、2、5、10 |
| 504 | Cesium borodeuteride 11B | 1、2、5、10 | |
| 462 | Rubidium borohydride 11B | CAS [1417734-37-2] | 1、2、5、10 |
| 505 | Rubidium borodeuteride 11B | CAS [1445366-23-3] | 1、2、5、10 |
| 300 | Dimethylamine borane complex, DMAB | CAS [74-94-2] | 10、25、100、250、1000 |
| 415 | Ammonia borane complex | CAS [13774-81-7] | 10、20、50、100 |
| 415,1 | Ammonia borane complex +90% (purity >90%) | CAS [13774-81-7] | 10、20、50、100、200、500、1000 |
| 294 | Triethylamine borane complex | CAS [1722-26-5] | 10、50、100、500 |
| 221 | Dimethylsulfide borane complex, 10M solution in Me2S (d=0.8g/ml 26°C) | CAS [13292-87-0] | 100、800 |
| 375 | Ammonia borane complex 10B | CAS [77074-21-6] | 1、5、10 |
| 468 | Ammonia borane complex 11B | CAS [77069-36-4] | 1、5、10 |
| 563 | Deuteroammonia deuteroborane complex 11B | CAS [933675-78-6] | 1、2、5 |
| 577 | Deuteroammonia deuteroborane complex | CAS [20214-17-9] | 1、2、5 |
| 435 | Triethylamine deuteroborane complex | CAS [4680-65-3] | 10、25、50、100 |
| 311 | Triethylamine borane complex 10B | CAS [115959-96-1] | 10、25、50、100 |
| 449 | Triethylamine deuteroborane complex 10B | 10、25、50、100 | |
| 430 | Triethylamine borane complex 11B | 10、25、50、100 | |
| 411 | Triethylamine deuteroborane complex 11B | 10、25、50、100 | |
| 477 | Dimethylsulfide deuteroborane complex (purity > 95%) | CAS [117981-99-4] | 10、25、50、100 |
| 254 | Dimethylsulfide borane complex 10B(purity > 95%) | 10、25、50、100 | |
| 471 | Dimethylsulfide deuteroborane complex 10B(purity > 95%) | 10、25、50、100 | |
| 594 | Dimethylsulfide borane complex 11B(purity > 95%) | 10、25、50、100 | |
| 473 | Dimethylsulfide deuteroborane complex 11B(purity > 95%) | CAS [2230877-77-5] | 10、25、50、100 |
| 219 | 4-Borono-L-phenylalanine, L-BPA | CAS [76410-58-7] | 1、5、10、50 |
| 541 | Trimethylborate | CAS [121-43-7] | 5、10、50、100、400、800 |
| 268 | 4-Borono-L-phenylalanine 10B, BPA (also provide BPA produced by GMP.) | CAS [80994-59-8] | 1、10、50 |
| 436 | Trimethylborate 10B | CAS [4832-27-3] | 5、10、50、100、400、800 |
| 262 | Tri-n-butylborate 10B | CAS [207742-80-1] | 10、50、100、400、800 |
| 344 | Triphenylborate 10B | 10、50、100、400 | |
| 409 | Trimethylborate 11B | CAS [3349-42-6] | 3、10、25、50 |
| 423 | Tri-n-butylborate 11B | CAS [207742-78-7] | 10、25、50、100 |
| 431 | Triphenylborate 11B | 10、25、50、100 | |
| 210 | Sodium mercaptododecaborate 10B, BSH | CAS [12448-24-7] | 1、5、10、50 |
| 268 | 4-Borono-L-phenylalanine 10B, BPA ( also provide BPA produced by GMP.) | CAS [80994-59-8] | 1、10、50 |
| 556 | Sodium decahydrodecaborate 10B, GB-10 | CAS [666747-96-2] | 1、5、10、25 |
| 230 | TODGA | CAS [342794-43-8] | 5、10、20、50、100 |
| 296 | DIHOCA dihexyloctanoyl amide | CAS [75397-93-2] | 5、10、20、50、100 |
| 611 | TEHDGA | CAS [669087-46-1] | 5、10、20、50、100 |
| 348 | 7Li-Lithium bromide | CAS [34007-72-2] | 5、10、20、50、100 |
| 553 | 7Li-Lithium iodide | CAS [29911-74-8] | 5、10、20 |
| 308 | 7Li-Lithium chloride | CAS [20233-17-4] | 5、10、20 |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://gropep.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技授权代理Katchem全系列硼化学产品"> 艾美捷科技授权代理Katchem全系列硼化学产品地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：18771997407
传真：17754422825
邮箱：sales@amyjet.com
0.3054
